McLean Hospital looks to Camden's Fox Hill for alcohol, drug rehab center
(8) Residential treatment facilities for comprehensive alcohol and related drug treatment programs providing concurrent treatment for addiction and/or other associated psychiatric disorders Such residential treatment facilities shall contain a minimum …
Read more on PenBayPilot.com

Northbound Treatment Services Now Addresses Women's Binge Drinking Problem
Northbound Treatment Services, the Southern California based alcohol and drug addiction treatment center, is now offering gender specific addiction treatment solution to the women's binge drinking problem sweeping the country. According to a recent …
Read more on PR Web (press release)

LA's Answer to Soho House
Max Russo, a 31-year-old native Angeleno who previously owned treatment centers for young adults with drug and alcohol problems, co-founded 41 Ocean. Mr. Russo grew up in a Hollywood household—his father helped discover Bette Midler and went on …
Read more on Wall Street Journal

Family Video Counseling Aids in Substance Abuse Treatment
30, 2012 /PRNewswire-USNewswire/ — When the best substance abuse treatment for a person's drug abuse or drug addiction isn't close to home, it makes it difficult for family members to participate in the treatment of a loved one. Recognizing family …
Read more on PR Newswire (press release)

Study: Fish in drug-tainted water suffer reaction
They come mostly from humans and farm animals; the drugs pass through their bodies in unmetabolized form. These drug traces are then piped to water treatment plants, which are not designed to remove them from the cleaned water that flows back into …
Read more on Laramie Boomerang

Global TB Fight Hits a Wall
Last year New Delhi made a historic policy reversal, scaling up a new strategy for treating drug-resistant patients. The change followed a Journal investigation in 2012 revealing that India, for years, had ignored evidence of increasing drug resistance …
Read more on Wall Street Journal- India

Diocese Sent Priests to Church-Run Center for Treatment
The Servants closed their Jemez Springs treatment center in the mid-1990s. One Los Angeles archdiocese priest, Michael Baker, was sent to Jemez Springs for a "renewal program" in early 1987 after he admitted to church officials that he had been …
Read more on Wall Street Journal

Promises Treatment Centers Celebrates 25 Years of Creating Extraordinary Lives
LOS ANGELES, Jan. 29, 2013 /PRNewswire/ — In honor of its 25th anniversary, Promises Treatment Centers will host a celebratory gala on February 1, 2013. Attendees will enjoy inspirational stories from Promises alumni and a speech by award-winning …
Read more on PR Newswire (press release)

Dwight Howard sitting out Friday
MINNEAPOLIS — Lakers star center Dwight Howard will not play in Friday's game against the Timberwolves and will return to Los Angeles to undergo the increasingly popular platelet-rich plasma therapy on his ailing right shoulder, the team announced.
Read more on ESPN

Rapid, On-site HIV Testing: Increases Life Expectancy and Is Cost-effective
Providing rapid HIV testing in drug treatment programs is also a good investment of health care dollars. This study demonstrated that providing onsite rapid HIV testing was cost-effective using the Cost Effectiveness of Preventing AIDS Complications …
Read more on AIDS.gov blog (blog)

The Clash of the Six-Figure Drugs
“We are on par with” the cost of current treatment for the disorder, said Paula Soteropoulos, a Genzyme official. (That treatment, called apheresis, uses a machine to filter bad cholesterol out of the bloodstream.) Of course, doctors and patients will …
Read more on Wall Street Journal (blog)

European Officials Say Drug Makers Paid to Delay Generic Version
While the companies have said the payments were legitimate, the European Union's antitrust chief said Thursday that the money probably changed hands to keep lower-cost versions of a drug called fentanyl off the market in the Netherlands. European …
Read more on New York Times

Drug Makers See Profit Potential in Rare Diseases
… be priced lower than its rival Juxtapid. But Kynamro still will cost $ 176,000 a year, according to Sanofi's Genzyme unit, which developed the drug with Isis Pharmaceuticals Inc. A year's treatment of Juxtapid costs $ 235,000 to $ 295,000, depending …
Read more on Wall Street Journal